Cite
HARVARD Citation
Takeda, T. et al. (2020). YES1 activation induces acquired resistance to neratinib in HER2‐amplified breast and lung cancers. Cancer science. 111 (3), pp. 849-856. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Takeda, T. et al. (2020). YES1 activation induces acquired resistance to neratinib in HER2‐amplified breast and lung cancers. Cancer science. 111 (3), pp. 849-856. [Online].